TSX:PRM.PR.A.PFD (Canada)
Â
5% PRF REDEEM 31/12/2022 CAD 10
C$
10.1
(0%)
Jul 16
Current and historical daily PE Ratio for Big Pharma Split Corp (
TSX:PRM.PR.A.PFD
) from 2017 to Jul 16 2025. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Big Pharma Split stock (TSX:PRM.PR.A.PFD) PE ratio as of Jul 16 2025 is 11.23.
More Details
Big Pharma Split Corp (TSX:PRM.PR.A.PFD) PE Ratio (TTM) Chart
Big Pharma Split Corp (TSX:PRM.PR.A.PFD) PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Total 0
- 1
| Big Pharma Split PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
Big Pharma Split Corp (TSX:PRM.PR.A.PFD) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Big Pharma Split Corp
NAICS : 523930
SIC : 7214
ISIN : CA08934P2070
Share Class Description:
TSX:PRM.PR.A.PFD: 5% PRF REDEEM 31/12/2022 CAD 10Description
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers